ClinicalTrials.gov
ClinicalTrials.gov Menu

Lapatinib and Vinorelbine in Treating Women With HER2-Overexpressing Locally Advanced or Metastatic Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00513058
Recruitment Status : Completed
First Posted : August 8, 2007
Last Update Posted : January 14, 2014
Sponsor:
Information provided by (Responsible Party):
UNICANCER

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Actual Primary Completion Date : May 2010
  Actual Study Completion Date : April 2012